Iovance Biotherapeutics, Inc. (IOVA) is listed on NASDAQ in Biotech Stocks. It is $8.02, -2.91%, with a $3.6B market cap. RSI is 62.4, near overbought. The latest reported quarter beat estimates. Insiders were net buyers across the listed trades.
Technical Analysis
RSI (14) 62.4 Near Overbought
Market Cap $3.6B
Volume 6.8M
Fundamentals — 10-Q Q2 2026
Revenue $170.7M
Net Income $-126.4M
EPS $-0.29
Gross Margin 49.6%
Operating Margin -77.9%
Net Margin -74.0%
P/E Ratio -27.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Kirby Daniel Gordon | Chief Commercial Officer | Buy | 30,000 | $1.84 | $55,200 | 2025 Jun 5 |
| Puri Raj K. | Chief Regulatory Officer | Buy | 5,600 | $1.74 | $9,744 | 2025 May 23 |
| Vogt Frederick G | Interim CEO & General Counsel | Buy | 25,000 | $1.69 | $42,250 | 2025 May 14 |
| Maynard Ryan D | Director | Sell | 50,000 | $10.06 | $503,000 | 2024 Nov 12 |
| Dukes Iain D. | Director | Buy | 32,000 | $9.15 | $292,800 | 2024 Feb 20 |
| Rothbaum Wayne P. | Director | Buy | 5,000,000 | $9.15 | $45.8M | 2024 Feb 20 |
| McPeak Merrill A | Director | Buy | 250,000 | $9.15 | $2.3M | 2024 Feb 20 |
| McPeak Merrill A | Director | Buy | 10,000 | $5.56 | $55,600 | 2023 Sep 18 |
| Rothbaum Wayne P. | Director | Buy | 5,000,000 | $5.30 | $26.5M | 2023 Sep 15 |
| McPeak Merrill A | Director | Buy | 10,000 | $6.15 | $61,500 | 2022 Dec 21 |
| Rothbaum Wayne P. | Director | Buy | 10,000,000 | $6.50 | $65.0M | 2022 Dec 2 |
| McPeak Merrill A | Director | Buy | 10,000 | $6.31 | $63,100 | 2022 Nov 29 |
| Vogt Frederick G | Interim CEO & General Counsel | Buy | 1,000 | $5.98 | $5,980 | 2022 Nov 28 |
| McPeak Merrill A | Director | Buy | 10,000 | $6.18 | $61,800 | 2022 Nov 28 |
| Dukes Iain D. | Director | Buy | 10,000 | $6.10 | $61,000 | 2022 Nov 23 |
| Rothbaum Wayne P. | Director | Buy | 1,000,000 | $6.60 | $6.6M | 2022 Jun 1 |
| Vogt Frederick G | Interim CEO & General Counsel | Buy | 1,000 | $6.44 | $6,440 | 2022 Jun 1 |
| McPeak Merrill A | Director | Buy | 20,000 | $6.82 | $136,400 | 2022 May 31 |
| Weiser Michael | Director | Buy | 10,000 | $6.80 | $67,978 | 2022 May 31 |
| Maynard Ryan D | Director | Buy | 7,500 | $6.75 | $50,625 | 2022 May 31 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $25.20 | 55.8 | $4.0B |
| | $351.70 | 55.2 | $10.4B |
Take IOVA further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put IOVA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Iovance Biotherapeutics, Inc. next reports.
Set alerts on IOVA
Get notified when Iovance Biotherapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free